The Cancer Research Industry

Many volunteers world-wide commit themselves todissolving the clumps for more effective treatment.
raising funds for cancer research and cancer charities.Anti-oncogene products: specific portions of D.N.A.,
Many hundreds of thousands more work in thecalled oncogenes, that have an important role in
industry as carers, or researching, prescribing,promoting cancer growth. Drugs that interfere with
diagnosing and manufacturing drugs. Huge companiesthe production of oncogenes may be useful for the
spend fortunes on cancer research. After so long andfuture treatment of cancer.
so many billions spent what exactly has cancerGene therapy: research into the use of tumour
research revealed?suppressant genes is highlighted in the British National
There have been regular breakthroughs in ourCancer Plan as an important element. Essentially, bits
understanding of cancer, but little progress in itsof DNA are inserted to replace missing or damaged
treatment. Modern research into cancer began in thegenes, possibly preventing the development of
1940's and 50's when scientists isolated substancescancer in someone who might be 'high risk'.
that killed cancer cells growing in a petri dish, orVaccines: very quietly the search for a general cure
leukaemia cells in laboratory mice. Early successes infor cancer is being put aside in preference to finding
chemotherapy set the pace and received mucha vaccine. The whole idea of a cure or treatment
media exposure, even though they only applied tothat is 'the same for everybody' breaks down in the
5% of cancer treatments at most.case of the specific, chaotic conditions that cause
Serving humanity by solving its major diseases has acancer in an individual person. After billions spent on
celebrity status, there is a lot of kudos and an air ofresearch for the holy grail of a cancer cure, the
Hollywood involved in such things. Cancer research issearch is now on to find a vaccine.
high profile activity and every now and then aAt a recent cancer immunology conference in the US
scientific treatment is discovered that gains widetop immunologists from 21 nations attended lectures
recognition, such as the HPV-16 trial, but it onlyon the latest immunology topics such as:
applies itself to the treatment of a small percentage· cancer immunosurveillance
of cancers. Mass-media hype is part of the problem· immunoediting
of how we see cancer. Early discoveries set up an· cancer antigen discovery
expectation that there was a cure-all treatment, a· monitoring and analysing the immunological
'magic bullet' that would make its discoverer famousresponse to human cancer
by curing cancer across the world. The idea stems in· cancer vaccine development
part from aspirin, the original bullet that magically findsThe Cancer Vaccine Collaborative (CVC) was
its way to the pain and diminishes it. Even nowlaunched to much excitement. It is a unique research
boasts of 'paradigm shifts' in orthodox cancer careprogram that should improve how cancer vaccines
are exaggerated.are developed, based on a collaboration of six New
In the 1950's and 60's huge and expensive researchYork medical centres and one in Minnesota. The aim
projects were set up to test every knownof their research is to find out how to effectively
substance to see if it effected cancer cells. Youimmunise against cancer using a vaccine, using 'action
might remember the discovery of the Madagascarresearch'.
Periwinkle (Catharansus Roseus), which revealedVaccines made from donor blood are proving to
alkaloids (vinblastine and vincristine) that are still usedwork for some cancers. Experiments with bone
in chemotherapy today. Taxol, a treatment formarrow transplants show there are about 40,000
ovarian and breast cancer originally came from thedifferent tissue types making it hard to find a match.
Pacific Yew tree. A treatment for testicular cancerUsually a perfect match can only be found within the
and small-cell lung cancer called 'Etoposide' waspatient's direct family. Incorrect matches can create a
derived from the May apple. In 'Plants Used Againsthost of secondary dis-eases. Scientist are finding
Cancer' by Jonathan Hartwell over 3,000 plants areways to train Killer T cells taken either from the host
identified from medical and folklore sources foror a donor, to more effectively attack cancer cells.
treating cancer, about half of which have beenThey have noticed that donor Killer T cells that are
shown to have some effect on cancer cells in a testalready 'primed' for a particular cancer (e.g. the donor
tube.body cells 'remember' the disease) can be highly
When these plants are made into synthetic drugs,effective. It may take many years to prove validity,
single chemicals are isolated and the rest of the plantreliability, safety and efficacy for this treatment.
is usually thrown away. The medicinally activeHarvesting the natural immunity of our own, or donor
molecules are extracted from the plant and modifiedcells with the aid of genetic engineering may well
until they are chemically unique. Then the compoundbecome a big player against modern immune
is patented, given a brand name and tested.attacking dis-eases.
In the first phase it will generally be tested onIncreased screening: this type of research looks at
animals, the second phase will decide dosage levelsgenetically identifying individuals who might be at high
and in phase 3 it is tested on people. By the time it isrisk of certain types of cancer and is partly a
approved by the Federal Drugs Authority (in U.S.A.)preparation for possible vaccines. Genetic counselling
or the Medicines and Healthcare Products Regulationis set to become a 21st century contributor to health
Agency (M.H.R.A.) in Britain, the development costscare based on prevention of disease as much as
for a new drug can reach five hundred million dollars,cure.
which eventually has to be recouped from theCombinations: research from West Germany
consumer.(Grossart-Maticek) argues that there is no single
In addition to 'treatment directed' research such ascause for cancer, similar to the pattern in most
finding chemicals that effect cancer cells, basicchronic illness. It shows there are environmental,
research continues apace, into differences betweenpsychological and spiritual dimensions to disease. The
normal and cancerous cells. In the last 30 years thisimplication is that treatment should be on the same
research has revealed much about our nature, but stilllevels, and that no single treatment is likely to be
no cure. Below are some current strands of scientificeffective because there is no single cause. This
research into cancer.antibody-guided therapy: this isobservation links with the position of many Holistic
the original 'magic bullet'. Cancer researchers usepractitioners who often have a wider view of health
monoclonal antibodies to carry poisons directly to thethan orthodox medical practitioners.
cancer cells without harming others.chronobiology:Dr. Robert Buckman is an experienced cancer
much of what happens in our bodies is governed byresearcher, and author of the informative book:
cycles, from the female monthly cycle to the cycles'What You Really Need to Know About Cancer'. He
of brainwaves. Human health depends on interactingsummarises what he sees as the present position of
cycles geared to acts of perception, breathing,scientific cancer research:
reproduction and renewal. Chronobiology analyses"We now have a very large number of ways of
these cycles in relation to different times, such aslooking at cancer cells in the laboratory. We have
day and night. Hormones, including stress and growththousands of different types of cancer cells growing
hormones, have their own cycles. For example theyin dishes, many of which can be grown and then
may be at their highest activity in the morning andcured in laboratory bred mice. We also have
quieter at night. Cancer cells seem to no longer obeythousands of different ways of looking at and testing
the same cycle rates as normal cells.those cells. We can look at the cells' growth, their
Anti-telomerase: one part of a cell, called theabilities to produce different substances, their
telomerase, governs the life cycle of a cell and howsensitivity to some chemotherapy drugs and their
many times it may multiply. Some cancer cells escaperesistance to others, the way they respond to
this control and can increase the number of timesgrowth factors, their genetic material including
they divide, becoming 'immortal'. Researchers hope tooncogenes and substances controlled by oncogenes,
gain control over cancer cells by stopping the actiontheir ability to effect other cells (of the immune
of telomerase.system, for example), their ability to damage
Anti-angiogenesis: secondary tumours (metastasis)membranes and invade, their structure under the
can persuade the cells around them to grow newelectron microscope and whether or not the cell
blood vessels to feed the tumours, supplying oxygensurface has any of hundreds of different marker
and nutrients for the growing cancer. This process ismolecules on it. These are just a few examples of
called angiogenesis and research here is finding wayswhat can be done nowadays: the complete list of
to stop the signals to normal cells that start theways in which cancer cells can be tested would
process.probably be longer than this entire book. But here is
Anti-adhesion molecules: Cancer cells form intothe snag: although this accumulation of experience is
clumps, unlike those in a petri dish which form into awonderful and commendable, cancer in human beings
flatter arrangement. When there are clumps of cellsis far more complicated then any laboratory system
they seem to possess a quality that resistscan ever be (at least in the light of current
treatment. This strand of research looks at waysknowledge)".
that can stop the cells clumping together, by